Pension & Benefits Daily™ covers all major legislative, regulatory, legal, and industry developments in the area of employee benefits every business day, focusing on actions by Congress,...
June 30 — A new lawsuit attacks Walt Disney's decision allowing workers to invest retirement savings in the Sequoia Fund and the stock of controversial drugmaker Valeant Pharmaceuticals Inc. ( Du Vall v. Inv. & Admin. Comm. of Walt Disney Co. , C.D. Cal., No. 2:16-cv-04743-GW-AJW, complaint filed 6/28/16 ).
In a proposed class action filed June 28, Disney workers allege that the company's retirement plan investment committee should have dumped its Sequoia Fund holdings when the fund's increasing stake in the troubled Valeant—which the workers dub “the Pharmaceutical Enron”—caused a substantial drop in stock price that led to lost retirement savings.
This isn't the first lawsuit attacking the Sequoia Fund's Valeant holdings under the Employee Retirement Income Security Act. A lawsuit making similar claims against Disney's plan committee and its trustee, Fidelity Management Trust Co., was filed in April and remains pending. In March, the fund's longtime manager, Ruane, Cunniff & Goldfarb Inc., was sued under the statute for investing an “enormous and imprudent amount” of retirement plan assets in Valeant stock.
In the June 28 lawsuit, the Disney workers question the retirement plan's decision to continue investing in the Sequoia Fund during a period when more than 30 percent of the fund's assets were in risky Valeant stock. The workers describe this decision as imprudent and in conflict with the plan's directive that investments be diversified.
The workers are particularly critical of the Sequoia Fund's decision to hold such a large stake in a single security. They contend that the 10 most common large-cap domestic stock funds hold no more than 6 percent of their assets in a single security—far less than the 30 percent Valeant stake held by the Sequoia Fund.
The lawsuit—which was filed in the U.S. District Court for the Central District of California—seeks to represent a proposed class of more than 50,000 participants in the Disney Savings and Investment Plan.
Peter K. Stris of Stris & Maher LLP in Los Angeles represents the Disney workers. Stris has become a familiar face in the U.S. Supreme Court by successfully arguing several ERISA cases, including lawsuits questioning a union health benefit fund's ability to sue participants and how 401(k) investors can hold fiduciaries liable for misconduct.
A spokesman for Disney declined to comment on the lawsuit.
To contact the reporter on this story: Jacklyn Wille in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Jo-el J. Meyer at email@example.com
Text of the complaint is at http://www.bloomberglaw.com/public/document/Patricia_Du_Vall_v_The_Investment_and_Administrative_Committee_of.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)